Feasibility of home dose optimization of apomorphine sublingual film in Parkinson’s disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover study

BACKGROUND: Dose optimization of sublingual apomorphine (SL-APO), a dopamine agonist for the treatment of OFF episodes in patients with Parkinson’s disease (PD), has been performed under clinical supervision in clinical trials. SL-APO may be a candidate for home dosing optimization which would be le...

Descripción completa

Detalles Bibliográficos
Autores principales: Kassubek, Jan, Stocchi, Fabrizio, Martinez, Ernest Balaguer, Pahwa, Rajesh, Ondo, William, Zhang, Yi, Bowling, Alyssa, Pappert, Eric, Isaacson, Stuart, Wu, Stacy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637145/
https://www.ncbi.nlm.nih.gov/pubmed/37954918
http://dx.doi.org/10.1177/17562864231209240

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10637145/
https://www.ncbi.nlm.nih.gov/pubmed/37954918
http://dx.doi.org/10.1177/17562864231209240

Ejemplares similares